Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes

Explore clinical trials studying Paraneoplastic Syndromes. Study availability and eligibility vary by location and protocol.

344 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes trial results

Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

NCT06447597

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Peking University First Hospital Beijing, China
  • The First Bethune Hospital of Jilin University Changchun, China
  • Xiangya Hospital Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
View all 18 locations
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details
Recruiting

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

NCT07221838

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Autoimmune Diseases, +15 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Schaumburg, Illinois, United States
  • Research Site Neptune City, New Jersey, United States
  • Research Site Raleigh, North Carolina, United States
View Trial Details
Recruiting

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

NCT06607627

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Norfolk, Virginia, United States
  • Research Site Joinville, Brazil
  • Research Site Salvador, Brazil
View all 13 locations
View Trial Details

Related conditions